recent
year
hospit
effluent
object
studi
research
variou
countri
throughout
world
face
differ
issu
specif
drive
inspir
forc
improv
knowledg
chemic
physic
character
wastewat
convent
paramet
name
bod
cod
tss
n
p
compound
ph
sarafraz
et
al
verlicchi
et
al
microbiolog
load
hospit
effluent
also
risk
spread
antibiot
resist
bacteria
boillot
et
al
chitni
et
al
differ
composit
hospit
effluent
urban
wastewat
uww
verlicchi
et
al
season
variat
hospit
effluent
composit
verlicchi
et
al
verlicchi
et
al
strategi
manag
cotreat
dedic
treatment
uww
verlicchi
et
al
evalu
adequaci
adopt
treatment
strategi
respect
remov
specif
contamin
mesdaghinia
et
al
beier
et
al
technic
econom
feasibl
dedic
treatment
train
hospit
wastewat
hww
pill
report
contribut
hospit
effluent
influent
municip
wastewat
treatment
plant
wwtp
verlicchi
et
al
santo
et
al
occas
occurr
diseas
outbreak
due
pathogen
occur
sewag
sar
sever
acut
respiratori
syndrom
china
led
scientist
develop
specif
research
project
identifi
safeti
measur
rapidli
adopt
exist
wwtp
particular
plant
receiv
hospit
effluent
deal
current
emerg
also
prevent
one
wang
et
al
quit
rare
nation
region
legal
regul
establish
defin
manag
treat
hospit
effluent
dispos
discharg
public
sewag
treatment
municip
wwtp
discharg
surfac
water
bodi
boillot
et
al
verlicchi
et
al
inde
hospit
effluent
still
gener
consid
pollut
natur
uww
thu
commonli
discharg
public
sewag
system
convey
urban
wwtp
subject
convent
treatment
often
consist
primari
clarif
activ
sludg
process
sometim
disinfect
practic
common
although
recent
studi
verlicchi
et
al
santo
et
al
mcardel
et
al
highlight
higher
concentr
pharmaceut
phc
disinfect
xray
contrast
media
occur
hospit
effluent
well
microbiolog
load
exhibit
higher
resist
treatment
chitni
et
al
municip
wwtp
conceiv
case
recent
upgrad
guarante
high
remov
effici
carbon
nitrogen
phosphoru
compound
well
microorgan
mainli
bacteria
pollut
regularli
arriv
occur
wwtp
influent
concentr
order
unit
p
compound
ten
nh
tkn
hundr
cod
bod
mgl
thousand
ml
escherichia
coli
commonli
adopt
treatment
municip
wwtp
includ
preliminari
treatment
sometim
primari
clarif
secondari
biolog
usual
consist
convent
activ
sludg
casprocess
polish
treatment
chemic
disinfect
sometim
rapid
filtrat
follow
uv
disinfect
unfortun
wwtp
adequ
enough
reach
high
remov
effici
wide
spectrum
micropollut
phc
adsorb
organ
compound
commonli
known
acronym
aox
commonli
present
hospit
effluent
also
among
main
sourc
antibiot
releas
environ
thu
may
promot
select
antibiot
resist
gene
arg
antibiot
resist
bacteria
arb
deepli
investig
rizzo
et
al
moreov
circumst
convent
treatment
adopt
hww
well
manag
low
effici
achiev
even
common
paramet
name
bod
cod
tss
total
coliform
mesdaghinia
et
al
sometim
simpl
primari
treatment
adopt
hospit
effluent
primari
clarif
prechlorin
effici
martin
et
al
case
treatment
adopt
direct
discharg
raw
hww
surfac
river
common
practic
liu
et
al
main
focu
studi
present
discuss
lesson
learn
previou
investig
studi
carri
dedic
treatment
hww
differ
countri
worldwid
offer
critic
analysi
data
collect
lab
pilot
full
scale
treatment
plant
act
primari
secondari
tertiari
step
attent
paid
remov
effici
observ
contamin
includ
convent
paramet
particular
emerg
one
mainli
phc
deterg
disinfect
analysi
also
compar
assess
invest
oper
cost
appli
technolog
studi
base
public
regard
investig
dedic
treatment
hospit
effluent
lab
pilot
full
scale
plant
act
primari
secondari
tertiari
step
carri
differ
countri
world
collect
data
present
discuss
herein
mainli
refer
observ
remov
effici
phc
belong
differ
class
analges
antiinflammatori
anaesthet
anthelmint
antibiot
antifung
antihypertens
antineoplast
antisept
antivir
betablock
contrast
media
fragranc
hormon
lipid
regul
psychiatr
drug
receptor
antagonist
stimul
tabl
supplementari
data
compil
select
compound
group
accord
class
moreov
convent
pollut
bod
cod
ss
n
p
compound
also
report
discuss
discuss
remov
effici
select
phc
observ
differ
treatment
technolog
step
particular
attent
paid
potenti
capac
technolog
retainingdegrad
specif
compound
possibl
oper
condit
could
maxim
data
present
graph
manuscript
detail
provid
tabl
supplementari
data
remov
valu
report
discuss
follow
graph
tabl
must
consid
necessari
caution
bear
mind
origin
may
affect
mani
factor
name
influent
characterist
macroand
micropollut
concentr
oper
condit
sludg
concentr
sludg
retent
time
srt
hydraul
retent
time
hrt
ph
temperatur
feed
tabl
main
chemic
characterist
hospit
effluent
term
convent
paramet
pharmaceut
emerg
compound
refer
conduct
boillot
et
al
verlicchi
list
studi
includ
overview
togeth
brief
descript
correspond
investig
rational
abd
elgawad
ali
investig
carri
four
hospit
egypt
assess
hospit
effluent
qualiti
quantiti
well
impact
environ
term
common
paramet
pollut
ca
system
adopt
treatment
prior
discharg
surfac
water
suitabl
hww
manag
base
standard
set
convent
pollut
uww
convent
paramet
bod
tss
total
coliform
faecal
coliform
trace
element
metal
alhashimia
et
al
investig
carri
real
wastewat
collect
hospit
locat
iraq
assess
perform
labscal
sequenc
anoxicanaerob
mbr
nutrient
remov
differ
intern
recycl
time
mode
anox
anaerob
condit
oper
srt
investig
carri
hospit
waldbrol
germani
assess
perform
fullscal
wastewat
treatment
plant
equip
mbr
evalu
characterist
activ
sludg
design
oper
paramet
see
beier
et
al
evalu
mbr
dedic
treatment
hww
reduc
environment
input
chemic
microbiolog
paramet
environ
convent
paramet
cod
toc
aox
nh
total
p
e
coli
enterococci
berto
et
al
investig
carri
hospit
brazil
evalu
effect
advanc
pretreat
consist
biolog
fullscal
septic
tank
chemic
stage
labscal
fenton
reactor
remov
organ
matter
pathogen
microbiota
hww
adequ
advanc
pre
treatment
hospit
effluent
reduc
environment
impact
convent
paramet
cod
bod
p
n
compound
suspend
solid
total
coliform
thermotoler
coliform
beyen
redai
investig
carri
hawassa
univers
referr
hospit
ethiopia
examin
suitabl
seri
full
scale
pond
treatment
hww
treatment
train
consist
two
facult
pond
surfac
area
depth
retent
time
follow
two
matur
pond
surfac
area
depth
retent
time
final
fish
pond
surfac
area
depth
retent
time
evalu
risk
pose
hww
term
convent
pollut
propos
upgrad
exist
wwtp
order
reduc
convent
paramet
cod
bod
p
po
total
nitrogen
nh
tss
td
cl
total
coliform
faecal
coliform
toxic
evalu
prechlorin
naclo
addit
effluent
infecti
tropic
diseas
depart
hospit
lyon
franc
toxic
evalu
due
prechlorin
convent
paramet
cod
toc
aox
chlorid
gautam
et
al
investig
carri
hospit
locat
vellor
tamil
nadu
india
mean
labscal
plant
consist
coagul
ad
fecl
mgl
rapid
filtrat
disinfect
ad
bleach
powder
solut
step
option
hospit
effluent
pretreat
discharg
public
sewag
lenz
et
al
investig
carri
hospit
vienna
austria
mean
pilot
mbr
l
instal
fed
oncolog
inpati
treatment
ward
effluent
ultrafiltr
membran
nomin
cutoff
kda
use
cancerostat
platinum
compound
lenz
et
al
investig
carri
oncolog
ward
hospit
vienna
austria
mean
pilot
mbr
see
lenz
et
al
follow
granular
activ
carbon
gac
uv
biomass
concentr
gl
averag
hydraul
load
ld
environment
risk
cytostat
cancerostat
platinum
compound
continu
next
page
investig
carri
brazil
pretreat
hospit
effluent
use
septic
tank
anaerob
filter
analysi
refer
occurr
remov
ciprofloxacin
result
risk
due
residu
treat
effluent
evalu
adequ
specif
pretreat
brazil
phc
ciprofloxacin
report
includ
detail
investig
describ
kovalova
et
al
kovalova
et
al
investig
remov
abil
phc
convent
pollut
upgrad
uf
membran
system
coupl
activ
sludg
reactor
addit
biofilm
support
media
aerat
tank
case
hospit
effluent
treatment
aerat
bioreactor
volum
l
uf
membran
system
consist
hollow
fibr
modul
surfac
area
pore
size
hrt
h
srt
improv
phc
remov
hospit
effluent
membran
function
result
reduct
oper
cost
phc
nardi
et
al
investig
disinfect
effluent
italian
infecti
diseas
ward
mean
differ
dose
clo
evalu
aox
product
kovalova
et
al
kovalova
et
al
kohler
et
al
mcardel
et
al
prado
et
al
investig
carri
brazil
involv
detect
enter
virus
hepat
hospit
effluent
effluent
two
differ
full
scale
treatment
plant
remov
effici
observ
two
sequenc
upflow
anaerob
sludg
blanket
uasb
three
serial
anaerob
filter
ca
system
follow
chlorin
tank
investig
compar
investig
pilot
scale
plant
consist
aerat
fix
film
biofilt
reactor
coupl
ozon
reactor
fed
effluent
malang
citi
hospit
indonesia
pollut
health
problem
human
caus
discharg
hww
convent
pollut
bod
phenol
faecal
coliform
pb
rezae
et
al
investig
carri
iran
pilotscal
system
consist
integr
anaerobicaerob
fix
film
reactor
fed
hospit
effluent
cotreat
urban
wastewat
potenti
reduct
organ
load
hospit
effluent
biolog
pretreat
cotreat
convent
paramet
cod
bod
nh
turbid
bacteria
escherchia
coli
shrestha
et
al
analysi
remov
perform
full
scale
two
stage
construct
wetland
cw
design
construct
nepal
treat
hospit
effluent
system
consist
three
chamber
septic
tank
horizont
flow
bed
depth
vertic
flow
bed
depth
bed
plant
local
reed
phragmit
karka
transfer
cw
technolog
develop
countri
reduc
pollut
aquat
environ
convent
paramet
tss
bod
cod
nh
po
total
coliform
e
coli
streptococci
sim
et
al
investig
carri
two
hospit
wwtp
locat
korea
assess
occurr
remov
select
pharmaceut
person
care
product
wastewat
treatment
plant
consist
floccul
fl
activ
carbon
filtrat
ac
ii
floccul
ca
potenti
risk
anthelmint
nontarget
organ
environ
resist
biodegrad
phc
person
care
product
suarez
et
al
investig
carri
spain
pretreat
hospit
effluent
efficaci
coagulationfloccul
coagfl
flotat
flo
process
remov
phc
investig
case
two
kind
hospit
effluent
one
radiotherapi
outpati
consult
ward
one
hospit
patient
surgeri
laboratori
radiolog
gener
servic
coagulationfloccul
assay
perform
jartest
devic
continu
pilotscal
plant
ferric
chlorid
fecl
aluminium
sulphat
al
ad
potenti
risk
hospit
wastewat
environ
phc
person
care
product
tss
cod
fat
vasconcelo
et
al
investig
carri
brazil
potenti
pretreat
hospit
effluent
degrad
persist
compound
particular
studi
investig
perform
labscal
photoinduc
oxid
heterogen
photocatalysi
ozon
peroxon
degrad
antimicrobi
ciprofloxacin
environment
impact
ciprofloxacin
analysi
degrad
ozon
photoprocess
ciprofloxacin
cod
venditti
et
al
investig
carri
luxembourg
remov
convent
pollut
select
phc
mean
pilot
mbr
fed
hospit
effluent
averag
bioreactor
consist
anoxicox
compart
respect
equip
two
submerg
microfiltr
membran
modul
pore
size
total
surfac
area
averag
hrt
h
temperatur
biomass
concentr
gl
srt
n
adequ
mbr
pretreat
hospit
effluent
common
phc
doc
cod
bod
total
n
total
p
verlicchi
et
al
investig
carri
brazil
degrad
mixtur
betablock
hospit
effluent
ozon
fenton
reaction
optim
oper
condit
degrad
mixtur
phc
hospit
effluent
atenolol
propranolol
metoprolol
mode
dosag
ozon
h
uv
irradi
catalyst
type
contact
time
reactor
type
convent
activ
sludg
system
membran
bioreactor
mbr
compartment
environment
condit
temperatur
irradi
water
sampl
mode
frequenc
discuss
main
result
deriv
studi
snapshot
main
chemic
physic
microbiolog
characterist
hww
provid
tabl
refer
also
provid
compil
paramet
class
compound
phc
eas
read
manuscript
brief
present
investig
report
tabl
list
investig
treatment
train
provid
tabl
correspond
refer
tabl
report
main
characterist
studi
includ
review
refer
dedic
treatment
hospit
effluent
rational
behind
one
rapid
glanc
tabl
point
hospit
effluent
subject
differ
treatment
level
preliminaryprimari
potenti
actual
dedic
treatment
cotreat
uww
municip
wwtp
sometim
convent
secondari
biolog
treatment
ca
modifi
ca
process
system
combin
attach
suspend
biomass
also
mbr
advanc
oxid
process
aop
countri
aop
investig
preliminaryprimari
treatment
order
enhanc
biodegrad
stream
order
help
read
review
tabl
list
type
investig
technolog
treatment
train
correspond
refer
distribut
differ
countri
world
found
graphic
abstract
well
larger
scale
fig
investig
refer
pilotlab
scale
plant
remain
full
scale
dedic
facil
see
tabl
sd
supplementari
data
latter
includ
follow
treatment
train
septic
tank
follow
anaerob
filter
brazil
de
almeida
et
al
martin
et
al
uasb
anaerob
filter
brazil
prado
et
al
seri
matur
facult
pond
ethiopia
beyen
redai
septic
tank
construct
wetland
hssf
vssf
bed
nepal
shrestha
et
al
mbr
germani
beier
et
al
beier
et
al
china
liu
et
al
wen
et
al
ca
chlorin
greec
kosma
et
al
brazil
prado
et
al
iran
mahvi
et
al
moreov
studi
carri
european
countri
austria
belgium
denmark
franc
germani
greec
itali
luxembourg
netherland
switzerland
turkey
asiat
countri
china
india
indonesia
iran
iraq
nepal
republ
korea
thailand
taiwan
south
america
brazil
africa
egypt
ethiopia
phc
detect
remov
effici
evalu
studi
includ
wherea
remain
one
refer
convent
paramet
studi
develop
europ
investig
phc
except
nardi
et
al
refer
prechlorin
raw
hospit
effluent
arslan
et
al
regard
aop
appli
raw
hww
worth
note
often
asian
countri
main
reason
investig
hospit
effluent
treatment
need
guarante
safe
treatment
kind
wastewat
evalu
possibl
directli
reus
treat
effluent
due
water
scarciti
variou
requir
particular
irrig
alhashimia
et
al
discuss
although
highli
appreci
problem
tackl
common
conclus
base
analysi
convent
contamin
wherebi
secondari
biolog
treatment
follow
chlorin
may
consid
adequ
treatment
even
case
direct
reus
back
comprehens
research
micropollut
ecotoxicolog
european
countri
main
reason
research
gener
awar
potenti
risk
pose
occurr
phc
residu
secondari
effluent
need
reduc
phc
load
discharg
environ
via
wwtp
effluent
live
debat
need
adopt
dedic
proper
treatment
hospit
effluent
ort
et
al
verlicchi
et
al
santo
et
al
base
evalu
contribut
health
care
structur
correspond
catchment
area
discharg
phc
follow
section
present
discuss
collect
data
remov
effici
select
phc
well
convent
paramet
hww
differ
system
act
primari
secondari
tertiari
step
specif
section
devot
remov
abil
microorgan
observ
differ
technolog
measur
suggest
reduc
spread
pathogen
also
antibiot
resist
bacteria
supplementari
data
provid
brief
overview
main
reaction
take
place
aop
might
help
read
follow
discuss
preliminari
treatment
gener
adopt
test
aim
remov
rough
coars
materi
raw
wastewat
thu
protect
mechan
electr
part
downstream
treatment
step
specif
treatment
also
test
lab
pilot
plant
reduc
toxic
chemic
mixtur
occur
hospit
effluent
enhanc
biodegrad
name
increas
bod
cod
ratio
improv
downstream
biolog
process
coagulationfloccul
flotat
process
satisfi
first
object
promot
remov
suspend
solid
colloid
wastewat
settl
spontan
gautam
et
al
suarez
et
al
wherea
ozon
chiang
et
al
aop
kajitvichyanukul
suntronvipart
satisfi
second
object
cod
remov
found
greater
mgl
ferric
chlorid
ad
raw
hospit
effluent
remov
increas
coagul
ad
settl
hww
follow
step
disinfect
calcium
hydrochlorid
reduc
microorgan
also
cod
found
contact
time
min
ca
clo
break
point
dose
mgl
gautam
et
al
studi
carri
effect
coagul
floccul
flotat
remov
phc
hospit
effluent
suarez
et
al
martin
et
al
fig
show
main
result
common
coagul
al
fecl
dosag
mgl
ad
raw
wastewat
without
flotat
process
particularli
effici
remov
phc
confirm
consider
report
verlicchi
et
al
fact
diclofenac
fragranc
remov
fig
also
report
somewhat
modest
remov
effici
observ
ciprofloxacin
use
septic
tank
follow
anaerob
filter
fed
raw
effluent
hospit
brazil
martin
et
al
attempt
improv
cod
remov
increas
biodegrad
raw
hospit
effluent
made
appli
ozon
uv
uvh
pretreat
arslan
et
al
base
lab
scale
test
effluent
diagnost
centr
nuclear
medicin
oncolog
radiolog
medic
genet
depart
found
highest
cod
remov
obtain
system
uvh
oper
ph
concentr
mgl
monochromat
uv
lamp
nm
dosag
h
ml
within
min
absorb
remov
best
aop
uv
fact
addit
h
led
scaveng
effect
hydroxyl
radic
result
lower
remov
effici
see
supplementari
data
detail
result
achiev
ozon
effluent
kidney
dialysi
unit
quit
interest
dose
mgl
ozon
contact
time
min
cod
reduc
mgl
mgl
ratio
bod
cod
increas
confirm
consist
increment
biodegrad
stream
chiang
et
al
anoth
option
improv
biodegrad
achiev
use
photofenton
process
see
supplementari
data
main
reaction
involv
found
hospit
effluent
averag
pollut
strength
cod
mgl
bod
cod
dosag
ratio
cod
h
fe
equal
reaction
ph
reaction
time
h
remov
effici
bod
cod
toc
bod
cod
ratio
increas
also
found
higher
cod
valu
optimum
reaction
condit
test
guarante
good
miner
organ
compound
enhanc
biodegrad
kajitvichyanukul
suntronvipart
increas
biodegrad
wastewat
also
confirm
batch
experi
raw
pretreat
effluent
subject
biolog
process
use
activ
sludg
found
case
pretreat
wastewat
remov
cod
amount
h
treatment
time
wherea
case
raw
hospit
effluent
kajitvichyanukul
suntronvipart
fenton
process
may
also
act
disinfect
step
fact
greatli
remov
total
coliform
thermotoler
coliform
document
berto
et
al
case
complet
remov
observ
investig
ascrib
acid
condit
occurr
hydroxyl
radic
low
ph
valu
would
caus
bacteria
death
would
assur
dna
denatur
studi
led
suggest
ozon
fenton
well
photofenton
process
suitabl
solut
preliminari
treatment
hospit
wastewat
technic
viewpoint
econom
analysi
would
necessari
assess
invest
oper
mainten
cost
moreov
adequ
adopt
advanc
technolog
pretreat
also
need
confirm
toxicolog
view
point
unfortun
avail
research
investig
studi
investig
capac
mbr
biolog
stage
treatment
hww
system
analyz
includ
ca
system
iran
mahvi
et
al
greec
kosma
et
al
egypt
abd
elgawad
ali
belgium
anaerobicaerob
fix
film
bioreactor
iran
rezae
et
al
aerat
fix
film
biofilt
indonesia
prayitno
et
al
move
bed
biofilm
reactor
denmark
andersen
et
al
ultrafiltr
membran
coupl
modifi
ca
reactor
addit
biofilm
support
franc
mousaab
et
al
matur
polish
pond
ethiopia
beyen
redai
horizont
vertic
subsurfac
flow
system
nepal
shrestha
et
al
fungal
bioreactor
spain
cruzmorato
et
al
first
part
section
mbr
ca
critic
analyz
compar
remain
system
analyz
compar
second
part
lesson
learn
review
studi
carri
world
regard
efficaci
mbr
appli
uww
remov
macroand
micropollut
verlicchi
et
al
certainli
use
analysi
perform
mbr
fed
hospit
effluent
regard
type
wastewat
special
attent
must
paid
evalu
potenti
inhibit
effect
biolog
activ
phc
heavi
metal
disinfect
deterg
occur
higher
concentr
hww
rather
uww
thu
risk
could
neg
affect
degrad
process
micro
contamin
assess
studi
includ
herein
hospit
effluent
gener
subject
coars
screen
mm
sometim
fine
screen
siev
mm
wherea
primari
clarifi
rare
adopt
hrt
h
adequ
pretreat
extrem
use
guarante
continu
oper
mbr
report
investig
verlicchi
et
al
raw
hww
may
contain
rag
filament
piec
cardboard
advers
interfer
move
part
within
wwtp
clog
membran
thu
effici
remov
start
treatment
train
agreement
suggest
gabarron
et
al
investig
differ
pretreat
process
find
adequ
technolog
would
consist
contribut
minim
rag
impact
mbr
perform
storageequ
tank
mbr
guarante
homogen
feed
avoid
damag
membran
unit
may
also
promot
sorption
remov
mechan
due
contact
solid
particl
micropollut
case
cancerogen
platinum
compound
cpc
cisplatin
show
high
affin
suspend
solid
lenz
et
al
studi
feed
oncolog
ward
first
collect
tank
h
resid
time
process
siev
separ
suspend
solid
liquid
phase
final
sent
mbr
treatment
cpc
concentr
significantli
reduc
pass
siev
membran
due
particl
biomass
sorption
onto
surfac
biolog
reactor
usual
consist
anoxicox
compart
promot
complet
nitrif
denitrif
p
remov
necessari
achiev
coprecipit
fecl
biomass
concentr
aerat
compart
vari
gl
sludg
retent
time
rang
except
mbr
oper
parallel
ca
system
whose
srt
ultrafiltr
membran
tubular
flat
sheet
frequent
investig
nielsen
et
al
lenz
et
al
pill
report
swiss
german
dutch
unit
within
project
microfiltr
membran
sheet
beier
et
al
luxembourg
unit
within
pill
project
pill
report
submerg
membran
modul
integr
bioreactor
commonli
adopt
configur
side
stream
modul
equip
dutch
unit
within
pill
project
austrian
investig
mbr
fed
oncolog
ward
effluent
lenz
et
al
rapid
glanc
macropollut
remov
observ
differ
mbr
show
notabl
high
valu
found
doc
cod
nh
around
nitrat
result
high
qualiti
permeat
reduc
variabl
interv
differ
pollut
doc
mgl
cod
mgl
total
n
mgl
except
wen
et
al
good
biolog
activ
gener
guarante
maintain
throughout
observ
period
differ
investig
chemic
physic
paramet
shock
could
occasion
occur
result
disturb
biolog
reactor
macroscop
point
view
reduc
remov
macropollut
name
cod
ss
n
compound
microscop
point
view
chang
modif
disintegr
activ
sludg
flock
mcardel
et
al
context
quaternari
ammonia
disinfect
potenti
critic
paramet
consumpt
may
greatli
vari
one
hospit
anoth
remark
kovalova
et
al
common
quaternari
ammonia
disinfect
bac
toler
concentr
may
reach
without
induc
neg
effect
biomass
kovalova
et
al
mcardel
et
al
moreov
hospit
laundrett
effluent
repres
hotspot
certain
pollut
kist
et
al
sudden
increas
formic
acid
concentr
may
occur
report
lead
ph
shock
bioreactor
result
process
perform
decreas
due
disintegr
sludg
consequ
dramat
decreas
cod
remov
fig
report
collect
data
remov
phc
hospit
effluent
mbr
oper
differ
srt
valu
underlin
differ
studi
clara
et
al
verlicchi
et
al
verlicchi
et
al
monteiro
boxal
srt
greatli
affect
remov
perform
mani
phc
long
srt
valu
promot
adapt
differ
kind
microorgan
presenc
slower
grow
speci
could
greater
capac
remov
recalcitr
compound
simultan
improv
suspend
solid
separ
kreuzing
et
al
base
data
shown
fig
observ
differ
sludg
age
emerg
srt
equal
promot
remov
atenolol
clarithromycin
slightli
higher
valu
around
enhanc
diclofenac
erythromycin
remov
around
larger
number
compound
better
remov
naproxen
lidocain
ciprofloxacin
sulfamethoxazol
cyclophosphamid
good
remov
effici
gener
observ
srt
greater
mani
select
compound
modest
remov
effici
observ
metoprolol
iopamidol
carbamazepin
gabapentin
ritalin
acid
unfortun
remov
effici
alway
scarc
variou
phc
name
indomethacin
phenazon
roxithromycin
ndealkylverapamil
metabolit
verapamil
cyclophosphamid
oseltamivir
carboxyl
propranolol
sotalol
iodixanol
iohexol
iomeprol
ioversol
oxazepam
antineoplast
agent
includ
cpc
group
show
higher
remov
effici
respect
cyclophosphamid
due
higher
affin
sorb
onto
particl
activ
sludg
flock
within
mbr
lenz
et
al
b
releas
sometim
occur
diclofenac
phenazon
ciprofloxacin
clarithromycin
sulfadiazin
sulfamethoxazol
propranolol
iopamidol
carbamazepin
probabl
due
deconjug
biolog
treatment
kovalova
et
al
nielsen
et
al
report
graph
fig
indepth
discuss
potenti
releas
mani
phc
report
verlicchi
et
al
well
monteiro
boxal
base
swiss
research
carri
within
pill
project
involv
compound
differ
therapeut
class
emerg
mbr
srt
equal
abl
remov
pharmaceut
metabolit
load
xray
contrast
media
exclud
although
remov
select
compound
poor
particular
clindamycin
diclofenac
furosemid
influent
contrast
media
load
remov
investig
mbr
mbr
satisfactori
treatment
process
remov
aox
permeat
aox
occur
rang
mgl
beier
et
al
mcardel
et
al
advanc
treatment
necessari
reduc
content
final
effluent
machado
et
al
absenc
suspend
solid
mbr
effluent
repres
strength
import
condit
requir
mani
advanc
technolog
remov
trace
contamin
suspend
solid
may
neg
interfer
remov
perform
said
technolog
mbr
appear
adequ
secondari
treatment
hospit
effluent
produc
good
qualiti
stabl
effluent
throughout
run
time
thu
suitabl
advanc
technolog
venditti
et
al
beier
et
al
includ
nfro
aop
full
scale
mbr
adopt
treatment
hww
itali
verlicchi
et
al
germani
pill
report
china
liu
et
al
two
research
project
found
deal
remov
phc
hospit
effluent
involv
dedic
ca
system
one
lab
scale
one
full
scale
kosma
et
al
pretreat
report
second
case
consist
grit
remov
mix
tank
biolog
reactor
anoxicaerob
compart
first
case
aerob
second
research
kosma
et
al
remov
effici
provid
phc
ca
hrt
h
chlorin
phc
monitor
dedic
ca
system
high
remov
effici
observ
ibuprofen
salicyl
acid
caffein
naproxen
gemfibrozil
paracetamol
ethynyl
estradiol
moder
remov
respect
wherea
scant
remov
found
carbamazepin
phenazon
respect
modest
releas
observ
diclofenac
research
ca
mbr
oper
parallel
fed
hospit
effluent
spike
mgl
respect
mbr
ca
system
exhibit
slower
start
prone
bulk
moreov
cod
remov
wors
ca
system
ca
vs
mbr
remov
variou
bacteri
group
total
coliform
faecal
coliform
total
anaerob
bacteria
log
unit
less
total
aerob
bacteria
log
unit
less
differ
found
remov
ca
mbr
higher
remov
effici
observ
bacteri
group
mbr
permeat
due
membran
retent
occurr
mbr
effluent
may
instead
explain
unavoid
bacteria
regrowth
effluent
vessel
permeat
collect
tube
also
absenc
proper
membran
clean
system
run
disinfect
appli
lesson
learn
previou
studi
remov
phc
mean
ca
mbr
fed
uww
verlicchi
et
al
b
highlight
mbr
combin
higher
biomass
concentr
aerat
basin
develop
differ
bacteri
speci
within
biomass
smaller
sludg
flock
may
enhanc
sorption
surfac
differ
contamin
higher
srt
higher
remov
suspend
solid
greatli
contribut
remov
phc
stream
moreov
discuss
passag
ultrafiltr
membran
guarante
disinfect
wastewat
thu
reduc
risk
spread
pathogen
bacteria
multidrug
resist
bacteria
recent
upgrad
mbr
system
research
mousaab
et
al
aim
improv
phc
remov
effici
membran
function
system
consist
activ
sludg
basin
coupl
extern
ultrafiltr
membran
modul
oper
srt
hrt
h
ph
first
work
usual
condit
hdpe
support
media
ad
biolog
reactor
specif
area
diamet
mm
length
mm
densiti
kgm
promot
develop
hybrid
attach
suspend
biomass
longer
srt
fix
organ
modifi
bioreactor
higher
remov
effici
observ
solubl
cod
vs
tss
vs
vss
vs
remov
effici
greater
codein
pravastatin
ketoprofen
diclofenac
roxithromycin
gemfibrozil
iohexol
wherea
unmodifi
mbr
remov
either
absent
low
presenc
biofilm
support
also
enhanc
particl
sorption
improv
effluent
qualiti
thu
offer
better
protect
membran
foul
reduc
clean
oper
enhanc
remov
p
compound
hospit
effluent
could
obtain
sequenc
anoxicanaerob
mbr
alhashimia
et
al
found
optim
phase
type
system
oper
intern
recycl
mode
h
anox
follow
h
anaerob
condit
provid
optim
simultan
remov
effici
n
compound
p
compound
express
ppo
nepal
dedic
treatment
plant
built
hospit
effluent
consist
three
chamber
septic
tank
provid
pretreat
follow
cw
system
horizont
subsurfac
flow
bed
deep
high
fill
mm
crush
gravel
vertic
flow
bed
deep
fill
clean
sand
secondari
step
good
remov
effici
observ
tss
bod
cod
nnh
total
coliform
e
coli
streptococcu
shrestha
et
al
ethiopia
seri
wast
stabilis
pond
facult
pond
matur
pond
fish
pond
cover
area
total
retent
time
found
reason
effici
remov
bod
cod
sulphid
suspend
solid
n
compound
hospit
effluent
beyen
redai
despit
satisfactori
remov
total
faecal
coliform
respect
final
concentr
fulfil
recommend
restrict
unrestrict
irrig
option
improv
qualiti
final
effluent
consid
instanc
adopt
construct
wetland
ii
two
success
lagoon
follow
infiltr
land
iii
mbr
advanc
oxid
treatment
better
remov
paramet
well
pharmaceut
iv
photofenton
process
reduc
toxic
first
option
consid
feasibl
wherea
second
could
lead
groundwat
contamin
applic
remain
option
found
difficult
term
cost
instal
oper
mainten
iran
hospit
effluent
gener
discharg
public
sewag
system
cotreat
urban
effluent
usual
subject
secondari
treatment
disinfect
mandatori
case
diseas
outbreak
critic
period
summer
autumn
due
reduc
river
water
flow
mahvi
et
al
common
malfunct
due
oper
inexperi
wwtp
neglig
wwtp
manag
author
investig
carri
pilot
plant
aim
evalu
proper
pretreat
hospit
effluent
discharg
public
sewag
system
follow
cotreat
rezae
et
al
ii
co
treatment
train
abl
respect
iranian
legal
requir
physic
chemic
microbiolog
paramet
direct
discharg
surfac
bodi
dispos
well
reus
agricultur
azar
et
al
investig
found
integr
anaerobicaerob
fix
film
bioreactor
greatli
remov
organ
nitrogen
compound
raw
hospit
wastewat
follow
cotreat
consist
primari
treatment
aerobicanaerob
activ
sludg
reactor
fulfil
legal
requir
convent
paramet
conclus
howev
consid
kind
recalcitr
compound
pharmaceut
contrast
agent
disinfect
whose
remov
poor
investig
biolog
system
anoth
treatment
train
investig
indonesia
consist
aerat
fix
film
biofilt
follow
ozon
reactor
satisfactori
remov
effici
observ
bod
faecal
coliform
pb
phenol
chemic
analysi
involv
pharmaceut
disinfect
deterg
prayitno
et
al
preliminari
treatment
addit
alreadi
report
section
chemic
floccul
follow
ca
process
repres
effici
barrier
anthelmint
drug
albendazol
flubendazol
consid
overal
remov
rang
sim
et
al
modif
biolog
reactor
enhanc
micropollut
remov
undergon
indepth
analysi
last
year
case
andersen
et
al
pilot
scale
combin
move
bed
biofilm
reactor
follow
ozon
stage
investig
biolog
system
develop
call
stage
mbbr
attempt
improv
creation
fix
biofilm
slowgrow
bacteria
would
stand
better
chanc
develop
bacteria
effici
remov
pharmaceut
compar
biomass
develop
ca
system
higher
remov
effici
observ
ketoprofen
gemfibrozil
occasion
diclofenac
clofibr
acid
interest
promis
result
observ
mani
phc
batch
fluidiz
bed
bioreactor
steril
nonsteril
condit
tramet
versicolor
pellet
cruzmorato
et
al
fed
hospit
effluent
oper
ph
g
dri
weight
biomass
per
litr
continu
addit
glucos
ammonium
tartrat
nutrient
sourc
biomass
steril
condit
show
versicolor
respons
remov
detect
compound
good
remov
effici
observ
analges
antiinflammatori
drug
complet
remov
observ
except
salicyl
acid
dexamethason
although
antibiot
partial
remov
requir
longer
time
analges
fungal
treatment
achiev
better
result
convent
activ
sludg
ca
process
verlicchi
et
al
b
part
case
ciprofloxacin
steril
nonsteril
condit
respect
vs
ca
clarithromycin
nonsteril
condit
vs
ca
higher
remov
effici
also
observ
antihypertens
valsartan
steril
nonsteril
condit
irbesartan
steril
nonsteril
condit
diuret
furosemid
steril
nonsteril
condit
vs
ca
diclofenac
complet
remov
observ
import
result
one
persist
compound
ca
also
potenti
candid
regul
european
legisl
hand
disadvantag
process
treatment
ph
neutral
necessari
secret
organ
acid
fungu
lower
overal
ph
concern
investig
carri
iran
iraq
indonesia
import
underlin
final
effluent
treatment
train
includ
ca
pond
gener
directli
reus
irrig
purpos
due
occurr
residu
phc
emerg
contamin
aop
includ
treatment
train
case
research
ecotoxicolog
characterist
final
effluent
carri
filtrat
pac
gac
undergon
indepth
investig
differ
european
research
group
fig
report
collect
data
case
includ
studi
pacgac
treatment
follow
mbr
fed
hospit
effluent
permeat
doc
rang
mgl
toc
around
mgl
nielsen
et
al
adsorb
use
swiss
research
pac
mcardel
et
al
surfac
area
g
particl
size
zero
surfac
charg
point
ph
pzc
equal
last
valu
repres
ph
carbon
surfac
mani
posit
neg
charg
function
group
valu
carbon
surfac
posit
charg
pac
reactor
good
mix
guarante
constant
concentr
adsorb
retent
time
differ
found
longer
time
good
separ
load
pac
treat
effluent
achiev
filtrat
uf
membran
flat
sheet
pore
size
pill
project
plant
pill
report
glass
fibr
filter
dutch
research
nielsen
et
al
nanofiltr
oppos
ultrafiltr
would
certainli
conveni
technic
view
point
improv
phc
remov
econom
one
nanofiltr
concentr
would
requir
dedic
treatment
due
high
concentr
micropollut
anoth
option
could
pump
load
activ
carbon
pac
reactor
mbr
recycl
consist
improv
remov
contamin
could
result
neither
process
research
investig
dose
pac
rang
mgl
swiss
german
research
studi
pill
report
mgl
dutch
studi
nielsen
et
al
former
rang
absolut
sustain
econom
view
point
defin
basi
cost
reason
remov
rate
wide
spectrum
micropollut
compound
latter
base
swedish
studi
remov
micropollut
aquat
environ
walhberg
et
al
pac
filter
effluent
doc
occur
mgl
pac
dose
mgl
pac
dose
mgl
mgl
pac
dose
mgl
within
swiss
campaign
appli
pac
dose
mgl
investig
pharmaceut
subject
high
remov
effici
wherea
compound
exhibit
remov
effici
intermedi
valu
mgl
remov
effici
greater
observ
compound
less
two
contrast
media
diatrizo
ioxitalam
acid
mgl
pac
dose
compound
high
remov
effici
n
two
contrast
agent
still
scant
remov
effici
rapid
glanc
result
achiev
within
dutch
research
nielsen
et
al
show
signific
differ
observ
remov
select
pharmaceut
appli
mgl
mgl
pac
comparison
dutch
campaign
pill
project
refer
compound
monitor
cite
studi
highlight
phc
higher
remov
effici
achiev
extrem
high
dutch
dosag
occur
antibiot
sulfadiazin
vs
high
dose
sulfamethoxazol
vs
two
dose
trimethoprim
vs
dose
contrast
agent
ifosfamid
vs
beta
blocker
atenolol
vs
attempt
correl
observ
remov
effici
phc
use
pac
sorption
potenti
express
term
k
ow
ow
also
account
acidbas
speciat
done
swiss
research
group
kovalova
et
al
mcardel
et
al
regard
neutral
ie
charg
compound
ph
name
carbamazepin
oxazepam
cyclophosphamid
iomeprol
iopamidol
iopromid
metronidazol
phenazon
primidon
found
higher
ow
valu
higher
observ
remov
sorption
contrari
agreement
experiment
data
predict
log
ow
sorption
remov
charg
compound
result
confirm
remov
mechan
consist
nonspecif
dispers
interact
electrostat
interact
well
charg
adsorb
surfac
ionic
adsorb
moreov
log
ow
influenc
behaviour
pharmaceut
also
pk
molecular
size
aromaticityaliphat
potenti
well
presenc
function
group
regard
pac
effect
remov
mechan
depend
surfac
area
pore
size
textur
surfac
chemistri
particular
function
group
point
zero
charg
miner
matter
content
rule
thumb
adsorpt
effect
compound
uncharg
apolar
interest
analysi
discuss
behaviour
mani
compound
report
kovalova
et
al
mcardel
et
al
consist
improv
remov
contrast
media
may
achiev
recycl
pac
biolog
treatment
document
micropol
project
zwickenpflug
et
al
gac
filtrat
investig
netherland
research
unit
within
pill
project
pill
report
also
austria
oncolog
ward
effluent
hospit
subject
first
mbr
gac
treatment
lenz
et
al
first
case
filter
bed
height
empti
bed
contact
time
min
fed
mbr
permeat
toc
equal
mgl
gac
filtrat
investig
pharmaceut
found
detect
limit
also
sulfamethoxazol
reluct
pac
sorption
remov
unfortun
data
refer
contrast
agent
collect
second
case
gac
filter
height
cm
cross
surfac
cm
flow
rate
lh
antineoplast
compound
cancerostat
platinum
compound
cpc
cisplatin
carboplatin
oxaliplatin
monitor
gac
influent
correspond
mbr
permeat
effluent
refer
total
pt
content
observ
gac
contribut
remov
rate
discuss
combin
uv
gac
lead
lesser
remov
rate
total
pt
may
due
fact
photodegrad
product
cpc
exhibit
lower
affin
activ
carbon
parent
compound
interest
observ
pac
gac
byproduct
occur
respect
oxid
process
ozon
aop
gener
oxid
photodegrad
compound
unavoid
often
ecotoxicolog
effect
ozon
investig
influent
ozon
reactor
alway
mbr
permeat
nielsen
et
al
cod
rang
mgl
doc
rang
mgl
ph
kovalova
et
al
contact
time
within
ozon
reactor
min
appli
dose
ozon
g
g
doc
pill
project
g
g
toc
studi
nielsen
et
al
higher
concentr
ozon
test
would
lead
format
potenti
toxic
bromat
accord
literatur
von
gunten
clearli
shown
fig
higher
appli
ozon
dose
greater
number
compound
remov
effici
lowest
test
valu
g
g
doc
german
unit
within
pill
project
pill
report
investig
compound
effici
remov
name
diclofenac
sulfamethoxazol
erythromycin
number
increas
select
compound
g
doc
kovalova
et
al
g
g
doc
kovalova
et
al
class
cytostat
contrast
agent
quit
reluct
remov
ozon
averag
remov
effici
observ
alway
lower
observ
class
mediumhigh
ozon
dose
compound
two
class
remov
occur
cyclophosphamid
ifosfamid
iopamidol
iopromid
dose
g
g
doc
g
g
toc
nielsen
et
al
reluct
compound
remov
ozon
contrast
agent
diatrizo
ioxitalam
acid
antibiot
metronidazol
anthelmint
flubendazol
whose
averag
observ
remov
effici
treatment
consist
decreas
cod
doc
ozon
elimin
miner
organ
matter
micropollut
rather
transform
degrad
compound
also
measur
cod
doc
quit
interest
point
ozon
seem
quit
promis
treatment
abat
micropollut
load
hospit
effluent
import
bear
mind
one
lesson
learn
pill
project
base
swiss
research
refer
top
administ
pharmaceut
investig
larg
hospit
mcardel
et
al
remov
effici
observ
phc
metabolit
load
icm
exclud
ozon
g
g
doc
ph
remov
reduc
contrast
agent
includ
could
lead
consider
sewag
convey
radiolog
ward
effluent
could
separ
treat
dedic
wwtp
could
also
possibl
recov
iodium
main
disadvantag
adopt
ozon
gener
aop
format
oxid
byproduct
like
bromat
due
matrix
compound
instanc
bromid
product
could
ecotoxicolog
effect
advis
adopt
biolog
step
name
sand
filter
mbbr
act
barrier
swiss
research
concentr
bromid
permeat
addit
highest
dose
ozon
g
g
doc
correspond
mg
l
bromat
found
concentr
well
swiss
drink
water
standard
set
ozon
reaction
due
select
attack
ozon
specif
function
moieti
organ
substanc
less
select
attack
hydroxyl
radic
ho
form
ozon
decomposit
wider
spectrum
function
group
within
molecul
ozon
decomposit
favour
presenc
hydroxyl
ion
oh
alkalin
ph
ph
n
follow
rule
thumb
could
lead
rough
predict
efficaci
ozon
remov
differ
type
micropollut
result
studi
kinet
ozon
reaction
potenti
correl
molecular
structur
presenc
kovalova
et
al
nielsen
et
al
lenz
et
al
moieti
within
molecul
compound
reactiv
ozon
lee
von
gunten
olefin
phenol
anilin
thiophenol
thiol
tertiari
amin
exhibit
high
reactiv
ozon
ii
secondari
amin
thioester
anisol
intermedi
reactiv
iii
primari
amin
nitro
group
slow
reactiv
iv
amid
react
ozon
compound
high
reactiv
ozon
alreadi
remov
high
extent
lowest
dose
g
g
doc
compound
intermedi
reactiv
benzotriazol
ritalin
acid
higher
remov
effici
observ
higher
ozon
dose
lowest
remov
effici
found
contrast
agent
without
moieti
investig
within
pill
project
pill
report
oncolog
ward
hospit
vienna
lenz
et
al
dealt
abil
contribut
uv
irradi
process
remov
phc
pretreat
hospit
effluent
one
uv
reactor
alway
fed
mbr
permeat
doc
mgl
main
characterist
test
equip
report
tabl
luxembourg
unit
low
medium
pressur
lp
mp
uv
lamp
use
run
polychromat
light
appli
water
stream
collect
data
report
fig
refer
lamp
type
appli
fluenc
observ
remov
effici
investig
compound
alway
less
uv
fluenc
jm
appli
jm
phc
remov
jm
compound
exceed
remov
threshold
uv
irradi
higher
fluenc
valu
remov
increas
instanc
jm
jm
mp
lamp
use
polychromat
light
produc
seven
investig
compound
success
remov
fig
clearli
show
except
cyclophosphamid
remov
effici
compound
rang
averag
compound
highest
remov
effici
lp
jm
diclofenac
lp
lamp
jm
diclofenac
lp
jm
sulfamethoxazol
lp
lamp
jm
diatrizo
lp
jm
sotalol
lp
jm
remain
x
ray
contrast
media
iomeprol
iopamidol
iopromid
ioxitalam
acid
lp
jm
last
result
quit
interest
uv
process
seem
effect
treatment
remov
wastewat
contribut
uv
process
remov
antineoplast
compound
found
neglig
conclud
lenz
et
al
monitor
cancerostat
platinum
compound
cpc
cisplatin
carboplatin
oxaliplatin
effluent
hospit
oncolog
ward
found
oxid
cpc
uv
lead
margin
reduct
total
pt
even
substanc
transform
oxid
total
amount
pt
remain
cyclophosphamid
remov
effici
found
higher
case
medium
pressur
uv
lamp
case
lp
lamp
vs
observ
uv
irradi
promis
technolog
remov
xray
contrast
media
appreci
result
observ
fluenc
jcm
appli
higher
valu
remov
differ
analges
antibiot
betablock
increas
kovalova
et
al
transmiss
uv
water
strictli
correl
water
turbid
low
turbid
recommend
order
greatli
reduc
potenti
interfer
water
matrix
excess
dosag
chemic
oxidis
may
act
scaveng
thu
inhibit
contamin
destruct
effici
uv
transmiss
subject
decreas
due
lamp
foul
reduc
lamp
foul
adequ
pretreat
necessari
insolubl
oil
greas
concentr
minim
heavi
metal
ion
concentr
maintain
concentr
less
mgl
remov
pharmaceut
advanc
oxid
process
includ
differ
technolog
aim
complet
oxid
andor
destroy
differ
kind
organ
pollut
water
wastewat
stream
h
co
miner
salt
one
character
varieti
radic
reaction
due
highli
reactiv
speci
mainli
hydroxyl
radic
also
superoxid
radic
anion
hydroperoxyl
radic
ho
roo
gener
site
differ
way
involv
combin
chemic
agent
name
ozon
hydrogen
peroxid
transit
metal
metal
oxid
auxiliari
energi
sourc
name
uv
irradi
electron
current
yradiat
ultrasound
studi
includ
combin
h
chemic
agent
uv
irradi
energi
sourc
primari
oxid
aop
unlik
mani
radic
nonselect
readili
react
mani
organ
pollut
occur
water
convert
hydrophil
compound
origin
one
brief
present
includ
main
reaction
occur
aop
report
supplementari
data
wherea
result
obtain
differ
investig
aop
appli
hospit
effluent
polish
treatment
present
fig
discuss
experiment
setup
test
switzerland
within
pill
project
photocatalysi
process
uvtio
compar
uv
process
alon
setup
includ
reaction
column
contain
four
conic
cartridg
consist
photocatalyt
fibr
titaniumdispers
silicabas
fibr
sinter
anatasetio
layer
surfac
around
low
pressur
uv
lamp
nm
v
w
overal
energi
consumpt
mwcm
nomin
fluenc
rate
protect
fibr
particl
contamin
two
prefilt
mesh
width
instal
elimin
rate
evalu
cycl
photocatalyt
chamber
uvtio
uv
remov
obtain
one
cycl
margin
anoth
interest
investig
carri
vasconcelo
et
al
aim
compar
degrad
ciprofloxacin
hospit
effluent
ozon
uv
irradi
uvtio
h
tio
uv
lab
scale
equip
use
tio
ad
suspens
mg
tio
ml
hospit
effluent
set
ph
enhanc
photocatalyst
activ
see
supplementari
data
process
detail
treatment
sampl
filter
membran
separ
tio
particl
solut
complet
remov
ciprofloxacin
observ
min
within
photocatalyt
reactor
result
obtain
min
uv
reactor
equip
w
medium
pressur
mercuri
lamp
uvtio
exhibit
better
remov
uv
compound
particular
sulfapyridin
gener
remov
effici
increas
factor
two
compound
without
photocatalyst
increment
cycl
slightli
improv
remov
contamin
xray
contrast
agent
achiev
higher
remov
effici
posttreat
result
led
consider
direct
phototransform
uv
domin
micropollut
remov
indirect
phototransform
due
presenc
embed
tio
occur
gener
remov
effici
observ
tio
uv
cycl
observ
cycl
use
uv
alon
lower
remov
effici
observ
uvtio
might
also
due
fact
photocatalyt
fibr
could
adsorb
uv
light
shade
part
reaction
chamber
thu
water
could
expos
less
uv
irradi
improv
remov
phc
observ
h
ad
uv
reactor
consist
differ
found
dosag
gl
gl
kohler
et
al
also
found
optimum
light
wavelength
uvh
system
nm
guarante
lowest
background
absorb
investig
water
high
h
absorb
result
effici
gener
hydroxyl
radic
consequ
lp
lamp
recommend
irradi
light
emit
nm
wherea
mp
lamp
emit
nm
light
total
emiss
good
result
obtain
lp
uv
irradi
aop
lead
consider
mani
phc
degrad
process
mainli
due
chemic
oxid
molecul
gener
radic
rather
direct
photolysi
kohler
et
al
wild
et
al
achiev
promis
result
thank
degrad
mixtur
betablock
atenolol
propranolol
metoprolol
hospit
effluent
pretreat
septic
tank
follow
anaerob
filter
fe
show
min
complet
degrad
parent
compound
observ
complet
elimin
degrad
process
found
strictli
correl
ph
alkalin
ph
valu
promot
remov
metoprolol
propranolol
wherea
acid
valu
enhanc
remov
organ
load
express
cod
investig
also
highlight
risk
undesir
byproduct
due
ozonolysi
intens
degre
recalcitr
respect
parent
compound
lead
better
investig
ecotoxicolog
characterist
polish
effluent
slight
increment
remov
micropollut
observ
ad
h
system
h
acceler
decomposit
ozon
partial
increas
amount
hydroxyl
radic
two
differ
applic
mode
test
within
pill
project
addit
h
ozon
reactor
influent
preozon
mbr
permeat
g
g
doc
addit
mgl
h
half
treat
wastewat
part
treat
g
g
doc
differ
observ
consid
signific
within
experiment
error
agreement
data
alreadi
publish
confirm
littl
improv
found
especi
water
rel
high
doc
acero
von
gunten
hydroxyl
radic
attack
less
effect
attack
signific
remov
effici
observ
high
dose
ozon
h
appli
permeat
test
nielsen
et
al
order
guarante
clear
polish
effluent
sometim
trap
step
follow
aop
reactor
context
effluent
pac
reactor
filter
uf
membran
flat
sheet
pore
size
switzerland
mcardel
et
al
moreov
within
pill
project
unit
move
bed
bioreactor
hrt
use
follow
pac
tio
uv
sand
filter
filtrat
veloc
v
f
b
mh
equip
ozon
pac
unit
disinfect
effici
strictli
correl
appli
technolog
tabl
report
efficaci
differ
treatment
appli
secondari
hospit
effluent
machado
et
al
secondari
hospit
laundri
effluent
kist
et
al
carri
brazil
main
influent
characterist
disinfect
step
ph
upstream
treatment
septic
tank
anaerobicaerob
treatment
fed
hospitallaundri
effluent
dose
mg
l
appli
equip
uv
lamp
emiss
nm
radiat
energi
jcm
catalyst
fixat
obtain
prepar
suspens
tio
chcl
mv
spread
plate
mg
tio
cm
contact
time
min
best
disinfect
effici
observ
combin
uvtio
also
provid
good
turbid
remov
ntu
surfact
mgl
b
detect
limit
toxic
ec
daphnia
magna
contact
time
min
result
concentr
ml
min
ml
disinfect
perform
due
damag
microorgan
cell
wall
cytoplasmat
membran
thu
cell
permeabl
increas
allow
intracellular
content
flow
membran
lead
cell
death
nanofiltr
revers
osmosi
nanofiltr
nf
revers
osmosi
ro
process
consid
potenti
polish
treatment
hospit
effluent
pretreat
mbr
technic
view
point
residu
phc
still
present
permeat
may
retain
due
molecular
weight
size
sorption
onto
membran
also
charg
membran
character
molecular
weight
cut
mwco
repres
weight
substanc
retain
sorption
potenti
remov
mechan
poorli
solubl
nonpolar
compound
neg
charg
compound
reject
nfro
membran
due
electrostat
repuls
compound
neg
charg
membran
surfac
kimura
et
al
moreov
water
characterist
ph
ionic
strength
hard
organ
matter
membran
biofoul
also
influenc
solut
reject
studi
beier
et
al
permeat
mbr
cod
b
mgl
mg
nl
equip
microfiltr
membran
subject
nf
ro
process
character
mwco
da
da
respect
found
ro
exhibit
higher
remov
select
phc
respect
nf
howev
ro
present
major
disadvantag
due
limit
yield
retent
properli
dispos
howev
suitabl
predict
model
develop
reject
differ
micropollut
nfro
process
specif
membran
siegrest
joss
data
avail
regard
remov
effici
phc
observ
final
chlorin
report
fig
refer
investig
carri
nielsen
et
al
ad
amount
clo
mgl
run
two
differ
contact
time
adopt
min
min
ciprofloxacin
show
higher
concentr
effluent
rather
influent
treatment
addit
chlorin
seem
abl
remov
diclofenac
studi
nielsen
et
al
concentr
influent
mbr
permeat
quit
low
b
ngl
effluent
ngl
min
contact
time
found
lab
scale
control
chlorin
surfac
water
diclofenac
exhibit
larg
degre
reactiv
final
concentr
detect
limit
westerhoff
et
al
countri
disinfect
mandatori
effluent
gener
infecti
diseas
ward
health
care
special
infecti
diseas
nardi
et
al
emmanuel
et
al
faecal
total
coliform
found
rang
ml
ml
respect
tabl
valu
lower
usual
found
raw
urban
wastewat
verlicchi
et
al
probabl
due
antimicrobi
activ
antibiot
disinfect
residu
present
infecti
diseas
ward
effluent
dosag
mgl
clo
contact
time
min
faecal
total
coliform
drop
less
ml
complet
remov
virus
alway
observ
nardi
et
al
predisinfect
raw
hospit
effluent
still
issu
great
concern
base
theoret
hypothesi
korzeniewska
et
al
recommend
preliminari
disinfect
hospit
effluent
immiss
public
sewag
order
minim
spread
antibiot
resist
bacteria
hand
research
emmanuel
et
al
found
disinfect
mean
naocl
effluent
infecti
tropic
diseas
depart
reduc
content
microorgan
time
toxic
effect
aquat
organ
mani
countri
includ
china
direct
chlorin
primari
treatment
follow
chlorin
repres
wide
use
method
treat
particular
disinfect
hospit
effluent
order
prevent
spread
pathogen
microorgan
liu
et
al
despit
fact
chlorin
disinfect
broad
spectrum
activ
bacteria
viru
fungi
simpl
use
may
produc
toxic
byproduct
perform
depend
water
qualiti
low
remov
effici
achiev
virus
greater
toler
chlorin
compound
bacteria
consequ
high
excess
disinfect
gener
appli
guarante
rough
disinfect
hospit
effluent
inevit
extrem
high
concentr
residu
chlorid
high
mgl
occur
result
seriou
pollut
problem
receiv
aquat
environ
remark
emmanuel
et
al
investig
effect
addit
naclo
hospit
effluent
greatli
reduc
bacteria
popul
toxic
effect
aquat
organ
china
avoid
excess
use
chlorin
remov
differ
type
microorgan
hospit
effluent
dealt
mean
mbr
mostli
employ
submerg
membran
pore
size
follow
chlorin
step
dosag
naclo
mgl
free
chlorin
contact
time
min
sinc
mani
plant
base
membran
technolog
built
treatment
hospit
effluent
capac
rang
complianc
sever
limit
ml
e
coli
liu
et
al
uf
mbr
follow
specif
disinfect
step
may
consid
viabl
option
remov
wide
group
bacteria
occur
hospit
effluent
studi
perform
reduc
pathogen
virus
still
scarc
remov
virus
mbr
substanti
due
three
mechan
viru
reject
depend
cake
gener
membran
surfac
viral
inactiv
biomass
adsorpt
onto
surfac
suspend
solid
make
microorgan
stabl
brazilian
investig
prado
et
al
remov
enter
virus
rotaviru
human
adenoviru
noroviru
genogroup
ii
hepat
virus
compar
two
differ
treatment
train
anaerob
one
includ
uasb
follow
three
anaerob
filter
aerob
one
consist
convent
activ
sludg
process
follow
chlorin
found
system
suit
remov
frequenc
detect
quantif
result
vari
accord
viru
type
effluent
come
differ
health
care
structur
mbr
equip
ultrafiltr
membran
abl
remov
group
bacteria
report
mainli
due
membran
retent
reduc
spread
multipl
antibiot
resist
strain
usual
occur
hospit
effluent
specif
disinfect
advis
order
avoid
regrowth
surviv
bacteria
discuss
inactiv
pathogen
possibl
remov
antibiot
resist
bacteria
uv
ozon
effici
respect
pac
gac
wastewat
disinfect
fluenc
appli
depend
requir
microorgan
limit
verlicchi
et
al
instanc
jm
appli
aim
guarante
ml
total
coliform
jm
concentr
ml
total
coliform
guarante
final
fluenc
greater
jm
residu
concentr
total
coliform
mpn
ml
thu
allow
unrestrict
irrig
disinfect
effluent
crite
tchobanogl
inactiv
specif
microorgan
oocyst
virus
request
fluenc
could
higher
inactiv
log
adenoviru
type
fluenc
jm
requir
wherea
inactiv
log
cryptosporidium
giardiasi
fluenc
jm
requir
hijnen
et
al
consider
lead
consider
ozon
uv
aop
gener
appli
hospit
effluent
remov
recalcitr
compound
time
disinfect
high
degre
order
guarante
safe
reus
disinfect
effluent
unrestrict
irrig
higher
fluenc
requir
well
studi
ecotoxicolog
characterist
water
comparison
perform
differ
analyz
secondari
tertiari
dedic
treatment
hww
depict
fig
term
number
investig
compound
number
compound
exhibit
remov
effici
greater
base
data
collect
phc
peer
review
paper
includ
manuscript
clearli
emerg
investig
technolog
mbr
pac
ozon
uv
best
result
perform
mbr
secondari
step
pac
tertiari
step
moreov
tabl
sd
supplementari
data
compil
compound
exhibit
remov
effici
greater
secondari
tertiari
treatment
correspond
refer
indepth
analysi
comparison
pair
treatment
perform
kovalova
et
al
respect
differ
class
phc
found
iodin
contrast
media
better
remov
mbr
uv
total
influent
load
select
phc
except
iodin
contrast
media
mbr
pac
mbr
uv
lesson
learn
campaign
led
consid
g
g
doc
mgl
pac
jm
uv
valu
best
satisfi
two
follow
choic
criteria
rel
good
abat
micropollut
reason
run
cost
kovalova
et
al
tabl
report
rough
estim
global
remov
differ
kind
class
respect
differ
technolog
base
collect
data
import
observ
choic
best
technolog
treatment
hospit
effluent
necessarili
lead
complet
remov
specif
parent
compound
remov
estrogen
activ
effluent
gener
reduct
ecotoxicolog
effect
bear
concept
mind
process
includ
tio
photocatalysi
seem
promis
technolog
abl
remov
estrogen
activ
byrn
et
al
coleman
et
al
aop
seem
promis
technolog
effect
remov
compound
affect
technolog
discuss
reaction
gener
fast
result
compact
reactor
final
low
chemic
dose
requir
lead
lower
residu
may
undesir
drawback
name
unselect
hydroxyl
radic
product
hydrophil
difficult
treat
byproduct
origin
one
clearli
list
suti
et
al
spread
diseas
due
pathogen
specif
strain
antibiot
resist
bacteria
counter
disinfect
step
korzeniewska
et
al
law
regul
includ
italian
deliber
interministeri
committe
date
februari
requir
treatment
effluent
health
care
structur
blood
analysi
laboratori
particular
effluent
infecti
diseas
ward
exampl
effluent
produc
larg
laboratori
blood
analysi
pievesestina
cesena
north
itali
effluent
flowrat
year
subject
ozon
filtrat
activ
carbon
prior
immit
public
sewag
system
cotreat
municip
wwtp
altern
addit
mgl
clo
contact
time
min
guarante
effici
remov
faecal
total
coliform
neglig
increment
aox
nardi
et
al
increment
consist
appli
disinfect
naclo
emmanuel
et
al
due
differ
natur
pollut
may
present
hospit
effluent
residu
phc
metabolit
disinfect
antisept
heavi
metal
radioel
pathogen
risk
pose
effluent
may
toxic
radioact
infecti
proper
manag
hospit
effluent
consid
must
includ
measur
mitig
consequ
wwtp
level
well
toward
environ
mani
studi
develop
order
investig
potenti
correl
observ
pharmaceut
remov
effici
achiev
differ
wastewat
treatment
pharmaceut
molecular
properti
among
cunningham
joss
et
al
roger
tadkaew
et
al
underlin
alway
difficult
find
reliabl
correl
mani
factor
ie
oper
environment
condit
affect
remov
mechan
complex
molecul
thu
wide
rang
variabl
gener
observ
remov
specif
compound
treatment
studi
refer
uww
led
rule
thumb
tri
correl
behaviour
specif
molecul
basi
properti
k
biol
k
k
ow
pk
discuss
report
tadkaew
et
al
verlicchi
et
al
lesson
learn
uww
may
also
use
make
rough
predict
efficaci
specif
treatment
hww
manag
moreov
attempt
correl
behaviour
common
paramet
cod
ss
specif
pharmaceut
hospit
wastewat
treatment
carri
unfortun
suggest
reliabl
relationship
emmanuel
et
al
vasconcelo
et
al
wild
et
al
interest
use
research
accomplish
deal
hospit
effluent
toxic
assess
environment
risk
pose
pharmaceut
residu
treat
hospit
effluent
boillot
et
al
perrodin
et
al
emmanuel
et
al
quit
complex
problem
beyond
aim
manuscript
lesson
learn
publish
studi
discuss
herein
point
concern
merit
research
well
known
hospit
effluent
toxic
urban
wastewat
due
high
concentr
deterg
disinfect
often
contain
chlorin
aldehyd
sodium
hypochlorit
glutaraldehyd
iodin
contrast
media
lead
gener
aox
drainag
network
heavi
metal
name
silver
use
radiolog
depart
radioel
inject
administ
nuclear
medicin
studi
complet
excret
urin
phc
residu
said
hospit
effluent
inhibit
activ
biomass
aerat
tank
sewag
facil
document
boillot
et
al
et
al
investig
often
base
microtox
acut
magna
test
emmanuel
et
al
boillot
et
al
also
batteri
includ
differ
kind
test
perrodin
et
al
lesson
learn
studi
suggest
differ
pollut
may
induc
contribut
toxic
name
free
chlorin
aox
emmanuel
et
al
ethanol
propanol
metal
includ
zn
cu
pb
boillot
et
al
environment
risk
assess
hospit
wastewat
gener
base
risk
quotient
rq
defin
ratio
phc
concentr
effluent
predict
noneffect
concentr
pnec
accord
classif
adopt
mani
studi
straub
verlicchi
et
al
santo
et
al
risk
classifi
high
rq
medium
b
rq
b
low
rq
base
measur
effluent
concentr
verlicchi
et
al
santo
et
al
found
raw
hospit
effluent
high
risk
pose
azithromycin
clarithromycin
erythromycin
ofloxacin
sulfamethoxazol
metronidazol
fluoxetin
ibuprofen
acetaminophen
iopromid
fact
pinpoint
adequ
treatment
necessari
hospit
wastewat
reduc
neg
effect
environ
bear
mind
framework
provid
al
anoth
sourc
risk
hospit
effluent
correl
occurr
antibiot
consist
potenti
develop
releas
antibioticresist
bacteria
arb
gene
arg
pill
project
pinpoint
risk
spread
resist
specif
antibiot
molecul
higher
hospit
effluent
urban
ww
effici
advanc
biolog
chemic
process
vari
rang
log
unit
ultrafiltr
mbr
guarante
consist
reduct
risk
wherea
follow
step
includ
ozon
sand
pac
filtrat
contribut
reduct
summari
invest
oper
mainten
cost
differ
scenario
report
tabl
refer
econom
evalu
carri
cite
studi
design
step
unfortun
homogen
alway
invest
oper
mainten
data
avail
invest
amort
year
depend
investig
tabl
offer
rapid
comparison
differ
technolog
order
magnitud
differ
treatment
train
mani
consider
may
aris
report
valu
exampl
emerg
previou
discuss
collect
remov
data
phc
activ
carbon
seem
promis
technolog
reduc
occurr
final
effluent
activ
carbon
requir
expens
mainten
oper
order
guarante
proper
perform
context
invest
cost
activ
carbon
filter
lower
anoth
aop
treatment
doc
level
stream
fed
carbon
filter
mgl
carbon
treatment
could
becom
uncompetit
aop
due
frequent
chang
regener
dispos
exhaust
carbon
moreov
gac
pac
destroy
microcontamin
allow
transfer
liquid
phase
solid
one
oper
cost
also
includ
cost
final
dispos
gac
pac
idea
potenti
cost
dedic
treatment
hospit
effluent
total
cost
rang
case
secondari
treatment
mean
mbr
polish
aop
except
kovalova
et
al
report
lower
total
cost
rang
around
differ
comment
two
research
group
within
pill
project
current
strategi
futur
perspect
treatment
hospit
effluentconclus
manag
treatment
hospit
effluent
greatli
vari
differ
countri
develop
one
may
complet
absent
mean
hww
directli
discharg
surfac
water
bodi
consist
simpl
chlorin
primari
clarif
follow
chlorin
primari
secondari
treatment
follow
chemic
disinfect
prayitno
et
al
variou
research
project
carri
countri
aim
evalu
suitabl
simpl
treatment
train
hospit
effluent
gener
refer
discuss
observ
remov
effici
convent
contamin
microorgan
possibl
directli
reus
reclaim
water
irrig
purpos
face
problem
aris
water
shortag
among
chitni
et
al
shrestha
et
al
beyen
redai
abd
elgawad
ali
suggest
improv
adopt
treatment
also
provid
view
applic
term
land
requir
footprint
cost
instal
oper
mainten
case
studi
report
herein
direct
reus
reclaim
water
evalu
includ
risk
pose
persist
emerg
contamin
acut
chronic
effect
environ
human
health
european
countri
effort
made
improv
remov
persist
compound
mean
endof
pipe
treatment
context
aop
technolog
research
one
studi
gener
refer
occurr
remov
consist
number
phc
well
ecotoxicolog
evalu
mean
risk
quotient
ratio
ie
ratio
maximum
measur
concentr
predict
noeffect
concentr
verlicchi
et
al
escher
et
al
differ
full
scale
wwtp
alreadi
construct
dedic
treatment
hospit
effluent
one
consist
preliminari
treatment
mbr
beier
et
al
mbr
follow
ozon
uv
verlicchi
et
al
ozon
pac
pill
report
ozon
gac
pharmafilt
report
grundfo
bioboost
interest
approach
adopt
franc
manag
treat
effluent
centr
hospitali
alp
annemass
thank
dedic
pipe
hww
convey
near
municip
wwtp
treat
specif
line
subject
continu
monitor
improv
remov
persist
compound
decis
taken
local
author
even
drawn
specif
law
site
sipibel
report
best
option
manag
treatment
hospit
effluent
strictli
correl
hospit
size
catchment
area
dimens
must
defin
basi
technic
econom
feasibl
studi
would
focu
appropri
measur
abl
reduc
macro
micro
pollut
load
discharg
surfac
water
environ
dedic
treatment
hospit
effluent
recommend
mani
author
worldwid
segreg
special
treatment
seem
adequ
specif
effluent
includ
effluent
gener
radiolog
ward
contain
icm
recalcitr
compound
extrem
high
concentr
also
effluent
laundri
oncolog
ward
clinic
analysi
laboratori
case
larg
central
italian
lab
servic
discuss
case
dilut
surfac
water
repres
proper
action
mitig
potenti
advers
neg
effect
phc
residu
environ
final
remark
suggest
studi
promot
implement
energyintens
system
indirect
solar
energi
aggreg
photovolta
cell
gener
electr
energi
may
result
energi
storag
balanc
use
energi
period
light
incid
lower
supplementari
data
includ
figur
tabl
refer
worldwid
distribut
treatment
train
technolog
investig
lab
pilot
full
scale
plant
includ
studi
togeth
correspond
refer
list
pharmaceut
includ
studi
reaction
involv
aop
process
list
compound
exhibit
remov
higher
secondari
tertiari
treatment
step
accord
studi
examin
review
studi
supplementari
data
associ
articl
found
onlin
version
http
